Artificial pancreas device systems for the closed-loop control of type 1 diabetes: what systems are in development?

S Trevitt, S Simpson, A Wood - Journal of diabetes science …, 2016 - journals.sagepub.com
Background: Closed-loop artificial pancreas device (APD) systems are externally worn
medical devices that are being developed to enable people with type 1 diabetes to regulate …

Physical activity and type 1 diabetes: time for a rewire?

SR Colberg, R Laan, E Dassau… - Journal of diabetes …, 2015 - journals.sagepub.com
While being physically active bestows many health benefits on individuals with type 1
diabetes, their overall blood glucose control is not enhanced without an effective balance of …

2 month evening and night closed-loop glucose control in patients with type 1 diabetes under free-living conditions: a randomised crossover trial

J Kropff, S Del Favero, J Place, C Toffanin… - The lancet Diabetes & …, 2015 - thelancet.com
Background An artificial pancreas (AP) that can be worn at home from dinner to waking up in
the morning might be safe and efficient for first routine use in patients with type 1 diabetes …

[HTML][HTML] A clinical overview of insulin pump therapy for the management of diabetes: past, present, and future of intensive therapy

C Berget, LH Messer, GP Forlenza - Diabetes spectrum: a …, 2019 - ncbi.nlm.nih.gov
A Clinical Overview of Insulin Pump Therapy for the Management of Diabetes: Past, Present, and
Future of Intensive Therapy - PMC Back to Top Skip to main content NIH NLM Logo Access keys …

Individualized model predictive control for the artificial pancreas: In silico evaluation of closed-loop glucose control

M Messori, GP Incremona, C Cobelli… - IEEE Control Systems …, 2018 - ieeexplore.ieee.org
Despite the continuous efforts devoted to AP development in the last decades, an artificial
pancreas (AP) system is not yet available on the market. One of the major issues involves …

Feasibility of long-term closed-loop control: a multicenter 6-month trial of 24/7 automated insulin delivery

B Kovatchev, P Cheng, SM Anderson… - Diabetes technology …, 2017 - liebertpub.com
Background: In the past few years, the artificial pancreas—the commonly accepted term for
closed-loop control (CLC) of blood glucose in diabetes—has become a hot topic in research …

The challenges of achieving postprandial glucose control using closed‐loop systems in patients with type 1 diabetes

V Gingras, N Taleb, A Roy‐Fleming… - Diabetes, Obesity …, 2018 - Wiley Online Library
For patients with type 1 diabetes, closed‐loop delivery systems (CLS) combining an insulin
pump, a glucose sensor and a dosing algorithm allowing a dynamic hormonal infusion have …

Care of diabetes in children and adolescents: controversies, changes, and consensus

FJ Cameron, DK Wherrett - The Lancet, 2015 - thelancet.com
Diabetes is one of the most common chronic medical disorders in children. The
management of diabetes remains a substantial burden on children with diabetes and their …

Automated closed-loop control of diabetes: the artificial pancreas

B Kovatchev - Bioelectronic Medicine, 2018 - Springer
Abstract The incidence of Diabetes Mellitus is on the rise worldwide, which exerts enormous
health toll on the population and enormous pressure on the healthcare systems. Now …

[HTML][HTML] The artificial pancreas in 2016: a digital treatment ecosystem for diabetes

B Kovatchev, WV Tamborlane, WT Cefalu… - Diabetes Care, 2016 - ncbi.nlm.nih.gov
With the increasing availability of continuous glucose monitoring (CGM) and continuous
subcutaneous insulin infusion (CSII), the artificial pancreas (AP)(the commonly accepted …